These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39414084)

  • 21. A Dose Escalation Clinical Trial of Single-Fraction Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer.
    Yamamoto N; Miyamoto T; Nakajima M; Karube M; Hayashi K; Tsuji H; Tsujii H; Kamada T; Fujisawa T
    J Thorac Oncol; 2017 Apr; 12(4):673-680. PubMed ID: 28007628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes of carbon-ion radiotherapy for locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2019 Feb; 110(2):734-741. PubMed ID: 30467928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbon-ion radiotherapy for octogenarians with locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Ishikawa H; Ogawa K; Tsuji H
    Jpn J Radiol; 2021 Jul; 39(7):703-709. PubMed ID: 33608792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Linear Energy Transfer Irradiation in Clinical Carbon-Ion Beam With the Linear Energy Transfer Painting Technique for Patients With Head and Neck Cancer.
    Kohno R; Koto M; Ikawa H; Lee SH; Sato K; Hashimoto M; Inaniwa T; Shirai T
    Adv Radiat Oncol; 2024 Jan; 9(1):101317. PubMed ID: 38260238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
    Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
    Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balancing benefits and limitations of linear energy transfer optimization in carbon ion radiotherapy for large sacral chordomas.
    Parrella G; Magro G; Chalaszczyk A; Rotondi M; Ciocca M; Glimelius L; Fiore MR; Paganelli C; Orlandi E; Molinelli S; Baroni G
    Phys Imaging Radiat Oncol; 2024 Jul; 31():100624. PubMed ID: 39206357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technical note: In silico benchmarking of the linear energy transfer-based functionalities for carbon ion beams in a commercial treatment planning system.
    Schafasand M; Resch AF; Traneus E; Glimelius L; Fossati P; Stock M; Gora J; Georg D; Carlino A
    Med Phys; 2023 Mar; 50(3):1871-1878. PubMed ID: 36534738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
    Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
    Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
    Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
    Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The LET trilemma: Conflicts between robust target coverage, uniform dose, and dose-averaged LET in carbon therapy.
    Fredriksson A; Glimelius L; Bokrantz R
    Med Phys; 2023 Dec; 50(12):7338-7348. PubMed ID: 37820319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
    Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
    Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage surgery for local recurrence after carbon ion radiotherapy for patients with lung cancer.
    Mizobuchi T; Yamamoto N; Nakajima M; Baba M; Miyoshi K; Nakayama H; Watanabe S; Katoh R; Kohno T; Kamiyoshihara M; Nishio W; Kamada T; Fujisawa T; Yoshino I
    Eur J Cardiothorac Surg; 2016 May; 49(5):1503-9. PubMed ID: 26468271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-averaged linear energy transfer per se does not correlate with late rectal complications in carbon-ion radiotherapy.
    Okonogi N; Matsumoto S; Fukahori M; Furuichi W; Inaniwa T; Matsufuji N; Imai R; Yamada S; Kanematsu N; Tsuji H
    Radiother Oncol; 2020 Dec; 153():272-278. PubMed ID: 32898559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation on the physical dose filtered by linear energy transfer for treatment plan evaluation in carbon ion therapy.
    Schafasand M; Resch AF; Nachankar A; Gora J; Traneus E; Glimelius L; Georg D; Stock M; Carlino A; Fossati P
    Med Phys; 2024 Jan; 51(1):556-565. PubMed ID: 37727137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
    Grün R; Friedrich T; Traneus E; Scholz M
    Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of gross tumor volume for definitive radiation therapy in patients with locoregionally recurrent non-small-cell lung cancer after surgical resection.
    Lee NK; Moon SH; Kim TH; Han JY; Yun T; Kim HT; Lee HS; Kim MS; Lee JM; Cho KH; Lee JS
    Clin Lung Cancer; 2013 Jul; 14(4):399-406. PubMed ID: 23276823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters.
    Karube M; Yamamoto N; Shioyama Y; Saito J; Matsunobu A; Okimoto T; Ohno T; Tsuji H; Nakano T; Kamada T
    J Radiat Res; 2017 Sep; 58(5):761-764. PubMed ID: 28992088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.